A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, MULTICENTER, EVENT DRIVEN PHASE III STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF FINERENONE IN ADDITION TO STANDARD OF CARE, ON THE PROGRESSION OF KIDNEY DISEASE IN SUBJECTS WITH
Principal Investigator(s)
Bansal,Shweta
Funded by
BAYER PHARMACEUTICAL
Research Start Date
Status
Active